why choose us

First received: May 17, 2023

Clinical Trial: Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ovarian Cancer

Study Type: INTERVENTIONAL


Official Title: A First-in-human, Single-center, Placebo-controlled, Randomized, Double-blind Study in Healthy Subjects to Evaluate Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam A

Brief Summary: The goal of this study is to learn more about the study candidate drug, KAND145, when given to healthy volunteers.The study will consist of two parts.In Part 1, the goal is to find out if the study drug KAND145 is safe and tolerable after a single dose.First, a small group of participants will receive a liquid for swallowing containing a low dose of the study drug or a liquid for swallowing that does not contain any drug.If this is safe and tolerable, higher doses will be given to subsequent groups of…

Read more